European Regulatory Science on Tobacco:

Policy implementation to reduce lung diseases

(LD-05)

This project has received funding from the European Union’s Horizon2020 research and innovation programme under grant agreement No 681109

The EU and the tobacco epidemic

• Efforts to reduce the devastation of tobacco-related deaths and illness include: European Tobacco Products Directive (TPD) WHO Framework Convention on Tobacco Control (FCTC)

• These two instruments provide the EU Member States with the framework of actions.

EU Tobacco Products Directive (TPD)Mandate for stronger tobacco productregulation of the:ManufactureMarketing and salesIngredients and additivesDisclosure to the public Directive 2014/40/EU*

*Had to be transposed into National law by May 2016

European Regulatory Science on Tobacco: Policy implementation to reduce lung diseases

To monitor and evaluate the impact of the TPD, withinthe context of WHO FCTC ratification at a Europeanlevel.

Overall Aim

64 researchersYoung groupGender balance

Objective 1To evaluate the psychosocial and behavioral impact of TPD implementation and FCTC implementation, through the creation of a cohort of adult smokers in 6 EU MS

EUREST-PLUS ITC cohort study• ITC 6 European Country Surveys

• Germany, Greece, Hungary, Poland, Romania, and Spain• Prospective longitudinal cohort study of adult smokers,

pre-post TPD design• Wave 1 (pre-TPD): June-September 2016 (N = 6011)• Wave 2 (post-TPD): February-May 2018 (N = 6027)

• Wave 2 included both re-contact respondents and replenishment respondents (cohort and repeated cross sectional)

Objective 2To assess support for TPD implementation through secondary dataset analyses of the Special Eurobarometer on Tobacco Survey

Smoking cessation

Objective 3To document changes in e-cigarette product parameters following TPD implementation

Warning labels

• The existence of the text only health warning labels on the

• box increased from 2.8% to 72.0% • vials from 19.6% to 32.7%• leaflet from 13.1% to 42.1%

• Overall, 86.0% post vs. 32.7% products before the implementation of the TPD (p<0.001).

Objective 4To enhance innovative joint research collaborations on chronic, respiratory drivers in vulnerable populations To enhance communication – knowledge transfer

EUREST-PLUS Publications (37 published – 20 accepted or under review)

• Baseline results published as a Special Supplement in Tobacco Induced Diseases

• 19 manuscriptshttp://www.tobaccoinduceddiseases.org/Issue-2-2018,6218

• Eurobarometer and Design monitoring publications

• 18 manuscripts - Different journals

• Cohort results will be published as a Special Supplement in the European Journal of Public Health

• 20 manuscripts

https://eurestplus.eu/

Website

https://youtu.be/n_qKRrvaP9c

YouTube video

Evaluating – Monitoring the Tobacco products directive

5 year follow up

Monitoring

Data Collection

Re-evaluation

Alteration of the

legislation

TAKE HOME POINTS I Have a clear plan – but don’t be afraid to make changes

during the project –you will need to. Choose your partners wisely Cooperatively Had a “good time” It’s a looooooooong process Do NOT randomly select your partners

Engage young researchers – they have enthusiasm, potential and time (win win situation).

Plan from the beginning what are your results and who your results are relevant to (your selling audience).

TAKE HOME POINTS -Implementation

• Build in the learning curve

• Continuous monitoring and updating against milestones

• Create your “Evidence based” research (papers)

• Ensure quality vs. time (don’t cut corners)

• It’s a “team sport”

European Regulatory Science on Tobacco: Policy implementation to reduce lung diseases

(LD-05)

This project has received funding from the European Union’s Horizon2020 research and innovation programme under grant agreement No 681109